PharmEasy Parent API Plans Rs 1,700 Cr NCD Issue To Repay Debt

PharmEasy Parent API to Raise Rs 1,700 Cr via NCDs for Debt Repayment.

Expert Analysis:

• Fundraising Plan: API Holdings, parent of PharmEasy, will raise Rs 1,700 crore through secured, redeemable NCDs, backed by Thyrocare shares as collateral.

• Debt Repayment: Funds will repay existing NCD obligations worth Rs 1,545.4 crore, linked to an earlier Rs 1,820 crore issuance.

• Stake Pledge Revision: Docon Technologies will pledge up to 61 per cent of its Thyrocare stake, reduced from 71.06 per cent earlier.

• Strategic Moves: PharmEasy’s fundraising supports its debt-reduction strategy to boost liquidity and revive IPO plans, alongside leadership changes with Siddharth Shah becoming vice-chairman and Rahul Guha taking over as CEO.

• Financial Performance: PharmEasy reported a consolidated loss of Rs 2,531 crore in FY24, nearly halving year-on-year losses through a 20 per cent expense cut.